Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × Aprepitant × 30 days × Clear all

Sponsor

Interventions

Dasatinib 2 ponatinib 1 pembrolizumab 1 nilotinib 1 decitabine and cedazuridine drug combination 1 Practice Management, Medical 1 Interviews as Topic 1 Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡